We found 3 result(s) matching your search for 'Human Leukocyte Antigen System (HLA System)'. Search again?
- Histocompatibility Antigens
- See Human Leukocyte Antigen System (HLA System).
- Human Leukocyte Antigen System (HLA System)
- Human Leukocyte Antigens (HLA), also known as histocompatibility antigens, are molecules found on all nucleated cells in the body. Histocompatibility antigens help the immune system to recognize whether or not a cell is foreign to the body. These antigens are inherited from one's parents. Human leukocyte antigens are used to determine the compatibility of kidneys and pancreata for transplantation from one individual to another. The major groups of HLA antigens are HLA-A, HLA-B, and HLA-DR. The values shown in this report are based on the six HLA antigens (two each for the A, B, and DR loci) reported for both donors and recipients. Tables reporting the level of HLA mismatch indicate the number of HLA antigens found in the donor that are not shared by the recipients. Generally speaking, the smaller the number of HLA mismatches the better the compatibility between donor organ and recipient.
- Mismatch
- See Human Leukocyte Antigen System (HLA System).
Available Terms:
ABO Blood Type
Actual Donor
Additional Donor
Advisory Committee on Organ Transplantation (ACOT)
Allocation Policies
Allograft
Annual Death Rate
Antibody
Antigen
Cadaveric Donor
Cadaveric Transplant
Cardiomyopathy
Censoring
Centers for Medicare and Medicaid Services (CMS)
Chimerism
Cockcroft-Gault Formula
Cohort
Cold Ischemia Time (CIT)
Compliance
Confidence Interval
Congenital Heart Disease
Coronary Artery Disease
Creatinine
Crossmatch
Death Rate
Deceased Donor
Division of Transplantation (DoT)
Donation Rate
Donation Service Area
Donor
Donor Cardiac Death (DCD)
DSA
DSA
Eligible Donor
Emphysema
End-Stage Organ Failure
End-Stage Renal Disease (ESRD)
Ethnicity
Expanded Criteria Donor (ECD)
Expanded Criteria Donor (ECD) Kidneys
FEV1
Final Rule
Glomerular Filtration Rate (GFR)
Graft
Graft Survival
Haplotype
HCFA
Health Resources and Services Administration (HRSA)
Heterotopic Transplant
Histocompatibility Antigens
Human Leukocyte Antigen System (HLA System)
Immunogenicity
Immunosuppression
Induction Therapy
Informed Consent
Inotropes
Justice
Living Donor
Median Time to Transplant
Median Waiting Time
Medical Urgency Status Codes
Medical Urgency Status Codes for Heart Allocation (1999-2002)
Medical Urgency Status Codes for Heart Allocation (Pre-1999)
Medical Urgency Status Codes for Liver Allocation (1997)
Medical Urgency Status Codes for Liver Allocation (1997-2000)
Medical Urgency Status Codes for Liver Allocation (Pre-1997)
Mismatch
Model for End-Stage Liver Disease (MELD)
National Organ Transplant Act (NOTA)
Nonheartbeating Donor
OPO
Organ Preservation
Organ Procurement
Organ Procurement and Transplantation Network (OPTN)
Organ Procurement Organization (OPO)
Panel Reactive Antibody (PRA)
Patient Survival
Pediatric End Stage Liver Disease (PELD) Scoring System
Percentile
Procurement
Race
Recipient
Rejection
Scientific Registry of Transplant Recipients (SRTR)
Sensitization
Standard Error
Thoracic Organs
Time to Transplant (TT)
Tissue Type
Transplant Center
Transplant Program
Tumor
United Network for Organ Sharing (UNOS)
University Renal Research and Education Association (URREA)
Utility
Vascular
Ventricular Assist Device (VAD)
Waiting List
Waiting List (Active)
Waiting List (Inactive)
Waiting List (Removal)
Waiting Time